Open company graph database — free web & API
Login

OrthoActiVolution Holdings Inc.

OrthoActiVolution Holdings株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
5
§01

Basic information

BASIC
Head office
1-50-1 Sasazuka, Shibuya-ku, Tokyo, Daiwa Sasazuka Tower
Chief executive
Manabu Ishikawa
Capital
100,000,000
Employees (non-consolidated)
Employees (consolidated)
Start date
2024-07-12
End date
§02

Websites

1 DOMAINS
§03

Business

1
Development of management strategies and management of group companies, etc.
§04

Related companies

5 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Osferion Biomaterials Inc.
Group
FH ORTHO SAS
Group
Japan Tissue Engineering Co., Ltd.
Group
Kiraboshi Bank Co., Ltd.
Bank
Polaris Capital Group Inc.
Shareholder
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

1 EVENTS

OrthoActiVolution Holdings Inc. was established in 2024 as the holding company for its group operating companies.Sources

§07

News

6 ARTICLES

OSferion Biomaterials Selected for Next-Generation Medical Device Support ProgramSources

On July 21, 2026, OSferion Biomaterials was selected to receive support under the FY2027 Next-Generation Medical Device Development Support Program. The program aims to revitalize Shizuoka Prefecture’s medical industry. OAV and OSB plan to continue developing high-performance medical devices.

OSferion Biomaterials Selected for FY2027 Medical Device GrantSources

OSferion Biomaterials was selected for a grant from the Shizuoka Industrial Promotion Foundation. The grant supports domestic medical device manufacturing, digitization, and telemedicine development. OSB plans to continue research and development and commercialization.

OSferion and J-TEC Partner on Joint-Preserving Knee TreatmentsSources

OSferion Biomaterial and Japan Tissue Engineering have formed a business partnership to develop knee joint-preserving treatments combining regenerative medicine and osteotomy. Joint product development and promotion are scheduled to begin in August 2026.

OrthoActiVolution Holdings Group Company Selected for FY2026 Medical Device GrantSources

OSferion Biomaterials Corp., a group company of OrthoActiVolution Holdings, was selected for a grant from the Shizuoka Industrial Foundation. The grant aims to strengthen the foundations of the medical device industry and support domestic commercialization, digitalization, and remote and contactless solutions. The company plans to continue medical device research and development.

OrthoActiVolution Holdings Group Company Selected for Next-Generation Medical Device Support ProgramSources

OSferion Biomaterials Corp., a group company of OrthoActiVolution Holdings, was selected on October 27, 2025, for the FY2026 Next-Generation Medical Device Development Support Program. The program aims to revitalize Shizuoka Prefecture's medical industry, and the company plans to use it to continue contributing to the development of high-performance medical devices.

Japanese Consul Visits FH ORTHO SASSources

A November 10, 2025, news item from OrthoActiVolution Holdings Co., Ltd. reported that a Japanese consul visited FH ORTHO SAS. The notice does not provide further details.

§09

Sources & updates

SOURCES
↑